[1]
|
Gelain, M.E. and Bonsembiante, F. (2019) Acute Phase Proteins in Marine Mammals: State of Art, Perspectives and Challenges. Frontiers in Immunology, 10, Article 1220. https://doi.org/10.3389/fimmu.2019.01220
|
[2]
|
Seigel, T.A., Cocchi, M.N., Salciccioli, J., Shapiro, N.I., Howell, M., Tang, A., et al. (2012) Inadequacy of Temperature and White Blood Cell Count in Predicting Bacteremia in Patients with Suspected Infection. The Journal of Emergency Medicine, 42, 254-259. https://doi.org/10.1016/j.jemermed.2010.05.038
|
[3]
|
Blann, A. (2014) Functions and Diseases of Red and White Blood Cells. Nursing Times, 110, 16-18.
|
[4]
|
Luan, Y., Yin, C. and Yao, Y. (2021) Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections. Frontiers in Immunology, 12, Article ID: 720363. https://doi.org/10.3389/fimmu.2021.720363
|
[5]
|
Black, S., Kushner, I. and Samols, D. (2004) C-Reactive Protein. Journal of Biological Chemistry, 279, 48487-48490. https://doi.org/10.1074/jbc.r400025200
|
[6]
|
董金平. 全血C反应蛋白与血常规联合检验在感染性疾病诊断中的价值[J]. 航空航天医学杂志, 2023(9): 1050-1052.
|
[7]
|
李燕妮. 降钙素原及炎性因子在感染性疾病中的研究进展[J]. 临床医药文献电子杂志, 2018(6): 184-185.
|
[8]
|
Mustafić, S., Brkić, S., Prnjavorac, B., Sinanović, A., Porobić-Jahić, H. and Salkić, S. (2018) Diagnostic and Prognostic Value of Procalcitonin in Patients with Sepsis. Medicinski Glasnik, 15, 93-100. https://doi.org/10.17392/963-18
|
[9]
|
苏应仙, 林翀, 陈少文, 等. 血液中炎性指标与脓毒血症细菌感染患者病情的相关性研究[J]. 中国现代医学杂志, 2016(9): 97-100.
|
[10]
|
Covington, E.W., Roberts, M.Z. and Dong, J. (2018) Procalcitonin Monitoring as a Guide for Antimicrobial Therapy: A Review of Current Literature. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 38, 569-581. https://doi.org/10.1002/phar.2112
|
[11]
|
Eklund, K.K., Niemi, K. and Kovanen, P.T. (2012) Immune Functions of Serum Amyloid A. Critical Reviews in Immunology, 32, 335-348. https://doi.org/10.1615/critrevimmunol.v32.i4.40
|
[12]
|
Takata, S., Wada, H., Tamura, M., Koide, T., Higaki, M., Mikura, S., et al. (2011) Kinetics of C-Reactive Protein (CRP) and Serum Amyloid a Protein (SAA) in Patients with Community-Acquired Pneumonia (CAP), as Presented with Biologic Half-Life Times. Biomarkers, 16, 530-535. https://doi.org/10.3109/1354750x.2011.607189
|
[13]
|
Mayer, J.M., Raraty, M., Slavin, J., Kemppainen, E., Fitzpatrick, J., Hietaranta, A., et al. (2002) Serum Amyloid a Is a Better Early Predictor of Severity than C-Reactive Protein in Acute Pancreatitis. British Journal of Surgery, 89, 163-171. https://doi.org/10.1046/j.0007-1323.2001.01972.x
|
[14]
|
Cunnane, G., Grehan, S., Geoghegan, S., et al. (2000) Serum Amyloid A in the Assessment of Early Inflammatory Arthritis. The Journal of Rheumatology, 27, 58-63.
|
[15]
|
Zhang, Y., Zhang, J., Sheng, H., et al. (2019) Acute Phase Reactant Serum Amyloid A in Inflammation and Other Diseases. Advances in Clinical Chemistry, 90, 25-80.
|
[16]
|
Li, L. and Chen, C. (2020) Contribution of Acute-Phase Reaction Proteins to the Diagnosis and Treatment of 2019 Novel Coronavirus Disease (Covid-19). Epidemiology and Infection, 148, e164. https://doi.org/10.1017/s095026882000165x
|
[17]
|
Tanaka, T., Narazaki, M. and Kishimoto, T. (2014) IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harbor Perspectives in Biology, 6, a016295. https://doi.org/10.1101/cshperspect.a016295
|
[18]
|
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., et al. (1994) Defective Inflammatory Response in Interleukin 6-Deficient Mice. The Journal of Experimental Medicine, 180, 1243-1250. https://doi.org/10.1084/jem.180.4.1243
|
[19]
|
Ruzek, M.C., Miller, A.H., Opal, S.M., Pearce, B.D. and Biron, C.A. (1997) Characterization of Early Cytokine Responses and an Interleukin (IL)-6-Dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection. The Journal of Experimental Medicine, 185, 1185-1192. https://doi.org/10.1084/jem.185.7.1185
|
[20]
|
Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R. and Salem, R. (2020) The COVID-19 Cytokine Storm; What We Know So Far. Frontiers in Immunology, 11, Article No. 1446. https://doi.org/10.3389/fimmu.2020.01446
|
[21]
|
Tanaka, T., Narazaki, M., Masuda, K., et al. (2016) Regulation of IL-6 in Immunity and Diseases. In: Ma, X.J., Ed., Regulation of Cytokine Gene Expression in Immunity and Diseases, Springer, 79-88.
|
[22]
|
Middleton, F.M., McGregor, R., Webb, R.H., Wilson, N.J. and Moreland, N.J. (2022) Cytokine Imbalance in Acute Rheumatic Fever and Rheumatic Heart Disease: Mechanisms and Therapeutic Implications. Autoimmunity Reviews, 21, Article ID: 103209. https://doi.org/10.1016/j.autrev.2022.103209
|
[23]
|
Plebani, M. (2023) Why C-Reactive Protein Is One of the Most Requested Tests in Clinical Laboratories? Clinical Chemistry and Laboratory Medicine (CCLM), 61, 1540-1545. https://doi.org/10.1515/cclm-2023-0086
|
[24]
|
Ulich, T., del Castillo, J. and Guo, K. (1989) In Vivo Hematologic Effects of Recombinant Interleukin-6 on Hematopoiesis and Circulating Numbers of RBCs and WBCs. Blood, 73, 108-110. https://doi.org/10.1182/blood.v73.1.108.108
|
[25]
|
Afford, S.C., Pongracz, J., Stockley, R.A., Crocker, J. and Burnett, D. (1992) The Induction by Human Interleukin-6 of Apoptosis in the Promonocytic Cell Line U937 and Human Neutrophils. Journal of Biological Chemistry, 267, 21612-21616. https://doi.org/10.1016/s0021-9258(19)36655-4
|
[26]
|
Mihara, M., Shiina, M., Nishimoto, N., et al. (2004) Anti-Interleukin 6 Receptor Antibody Inhibits Murine AA-Amyloidosis. The Journal of rheumatology, 31, 1132-1138.
|
[27]
|
Okuda, Y. and Takasugi, K. (2006) Successful Use of a Humanized Anti-Interleukin‐6 Receptor Antibody, Tocilizumab, to Treat Amyloid a Amyloidosis Complicating Juvenile Idiopathic Arthritis. Arthritis & Rheumatism, 54, 2997-3000. https://doi.org/10.1002/art.22118
|
[28]
|
Nishida, S., Hagihara, K., Shima, Y., Kawai, M., Kuwahara, Y., Arimitsu, J., et al. (2009) Rapid Improvement of AA Amyloidosis with Humanised Anti-Interleukin 6 Receptor Antibody Treatment. Annals of the Rheumatic Diseases, 68, 1235-1236. https://doi.org/10.1136/ard.2008.099267
|